Neuropathological Assessment as an Endpoint in Clinical Trial Design
Crossref DOI link: https://doi.org/10.1007/978-1-0716-3774-6_15
Published Online: 2024-03-02
Published Print: 2024
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gentleman, Steve M.
Liu, Alan King Lun
Text and Data Mining valid from 2024-01-01
Version of Record valid from 2024-01-01
Chapter History
First Online: 2 March 2024